BRISBANE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company's management team will present at the TD Cowen Immunology & Inflammation Summit, which is taking place virtually from November 12-13, 2025. The management team will also participate in one-on-one investor meetings. Presentati ...

（股份代號：1152） 2025年11月10日下午12時正舉行之 股東特別大會投票表決結果 茲提述正乾金融控股有限公司（「本公司」）日期為2025年10月24日之股東特別大會 通告（「通告」）及通函（「通函」）。除另有說明者外，本公佈所用之詞彙與通函所界 定者具有相同涵義。 香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 佈 的 內 容 概 不 負 責，對其準確性或完整性亦不發表任何聲明，並表明不會就因本公佈全部或任何 部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 （於百慕達註冊成立的有限公司） * 各項決議案全文載於通告內。 – 1 – 由於超過50 %票數投票贊成上述第1 (A)、1 (B)及1 (C)項決議案，故該等決議案均 獲正式通過為本公司普通決議案。 同 時 ， 由 於 超 過 75 % 票 數 投 票 贊 成 上 述 第 2 項 決 議 案 ， 故 該 決 議 案 獲 正 式 通 過 為 本公司特別決議案。 於股東特別大會日期，已發行股份總數為982,000,000股。誠如通函所述，概無股 東須於股東特別大會上就上述決議 ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse commercial applications, today announced a CRISPR/Cas9 license agreement. This agreement grants Dyadic access to ERS' CRISPR/Cas9 patent portfolio, enhancing Dyadic's ability to accelerate strain engineering and pathway optimization to enhance product ...

"As we continue to closely examine the outcomes from our clinical trials, our confidence grows that ATH434 has the potential to profoundly impact MSA treatment and alter the course of disease progression," said David Stamler, M.D., Chief Executive Officer of Alterity. "Our recent presentation at AAS highlighted the effect of orthostatic hypotension (OH), a critical symptom of MSA that predicts rapid disease progression. It is clear that future studies will need to control for clinical parameters such as OH, ...

CHARLOTTE, N.C., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced third quarter 2025 financial results, highlighted by IM8's trajectory towards $120 million in annualized recurring revenue ("ARR") in just 12 months by December 2025. This unprecedented growth positions IM8 as having the fastest growth trajectory ever recorded in the global supplem ...

Siddhant Awasthi, Tesla's head of the Cybertruck program, recently announced on LinkedIn he was leaving the company after eight years. ...

Esperion Therapeutics, Inc. ( ESPR ) continues to execute under a cloud of market skepticism. While the stock has made an impressive recovery from the depths of skepticism in April and May, ESPR remains capped by important technical levels Analyst's Disclosure:I/we have a beneficial long position in the shares of ESPR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Al ...

Questions about Microstrategy's business model, copycat products and a stalling in the bitcoin price might have contributed to the decline in MSTR's mNAV. ...

11月10日，*ST元成发布公告称，公司于当日收到上交所下发的《关于拟终止元成环境股份有限公司股票上市的事先告知书》。截至2025年11月10日，公 司股票已连续20个交易日的每日股票收盘总市值均低于5亿元，根据相关规定，公司股票已经触及终止上市条件。 【导读】*ST元成收到拟终止公司股票上市的事先告知书 中国基金报记者 忆山 11月10日，*ST元成开盘跌停，在连续21日跌停后，公司股价跌至0.58元/股，公司市值降至1.9亿元。 同日，*ST元成收到《关于元成环境股份有限公司终止上市相关事项的监管工作函》。上交所在监管工作函中要求该公司及时披露并充分提示风险，做好 股票终止上市的有关工作。 此外，前期*ST元成收到的《行政处罚事先告知书》显示，公司2020年、2021年、2022年年报存在虚假记载且2022年非公开发行股票文件编造重大虚假内 容。上交所要求公司及全体董事及高级管理人员应妥善处理有关事项，保护上市公司利益，及时回应投资者关切，积极做好沟通解释工作。 今年10月，*ST元成收到证监会下发的《行政处罚事先告知书》显示，因年报虚假记载及非公开发行股票文件造假等事项，*ST元成被责令改正、给予警 告 ...

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Archer-Daniels-Midland Company (ADM) is an agribusiness company. The Zacks Consensus Estimate for its current year earnings has been revised 13% downward over the last 60 days. Associated British Foods plc (ASBFY) is a diversified food and retail company. The Zacks Consensus Estimate for its current year earnings has been revised 22.2% downward over the last 60 days. Burford Capital Limited (BUR) is a legal finance company. The Zacks ...